The INSPIRE-T longitudinal observational study centered on intrinsic capacity: baseline data

INSPIRE-T纵向观察研究以内在能力为中心:基线数据

阅读:2

Abstract

BACKGROUND: The "INStitute for Prevention," "healthy agIng," and "medicine REjuvenative" "Translational" (INSPIRE-T) study is a 10-year observational study. The primary objective of which is to study trajectories of aging across lifespan from the perspective of intrinsic capacity (IC) through deep clinical and biological phenotyping. METHODS: IC was assessed in the INSPIRE-T cohort stratified by age (10-year age groups) using the World Health Organization (WHO) integrated care for older people (ICOPE) program. Biospecimens (biofluids, dental plaque, nasopharyngeal swabs, stools, hair follicles, and skin biopsies) were also collected for biomarker studies and drug-target identification for the prediction and prevention of IC declines respectively. RESULTS: The INSPIRE-T baseline data is presented including demographic, health, anthropometric, lifestyle, and IC characteristics of the cohort. The open cohort (ongoing recruitment) currently consists of 1109 participants with data available at baseline (61.9% female) aged from 20 to 102 years old (mean age ± standard deviation: 62.4 ± 19.0 years). The most prevalent IC abnormalities identified using ICOPE Step 1. screening appeared to be in vision (89.3%), audition (30.5%), and cognition (24.7%) in the total baseline population, while locomotor capacity abnormalities (5.4%) appeared to be the least frequent. Sex-specific differences were observed for the domains of psychological well-being, audition, vitality in 30-39-year olds and vision in subjects ≤39 years old. CONCLUSIONS: The ultimate goal of INSPIRE-T is to enable the identification of individuals at risk of IC declines in order to implement personalized preventive interventions to promote healthy aging.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。